• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于开发用于重度抑郁症的台湾认知问卷(TCQ)的多中心研究。

A Multi-Center Study for the Development of the Taiwan Cognition Questionnaire (TCQ) in Major Depressive Disorder.

作者信息

Yen Yung-Chieh, Chiu Nan-Ying, Hwang Tzung-Jeng, Su Tung-Ping, Yang Yen-Kuang, Chen Cheng-Sheng, Li Cheng-Ta, Su Kuan-Pin, Lai Te-Jen, Chang Chia-Ming

机构信息

Department of Psychiatry, E-Da Hospital, Kaohsiung 824, Taiwan.

School of Medicine, I-Shou University, Kaohsiung 824, Taiwan.

出版信息

J Pers Med. 2022 Feb 26;12(3):359. doi: 10.3390/jpm12030359.

DOI:10.3390/jpm12030359
PMID:35330360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8949511/
Abstract

Cognitive dysfunction is associated with functional impairment of patients with Major Depressive Disorder (MDD). The goals were to explore the associated factors of cognitive impairment in MDD and to develop and validate a brief and culture-relevant questionnaire, the Taiwan Cognition Questionnaire (TCQ), among patients with MDD. This was a cross-sectional, multi-center observational study of MDD patients in Taiwan. Participants of Group 1 from 10 centers contributed to the validation of the TCQ by their response and sociodemographics. The participants of Group 2 from one center received an objective cognitive assessment for clarification of the relationship between the TCQ score and its associated factors. In Group 1, 493 participants were recruited. As for Group 2, an extra 100 participants were recruited. The global Cronbach's alpha for the TCQ was 0.908. According to the coordinates of the ROC curve, 9/10 was the ideal cut-off point. With the criteria, the sensitivity/specificity of the TCQ was 0.610/0.689. The TCQ score was positively associated with a history of being admitted to acute psychiatric care and the severity of depression and negatively associated with objective cognitive measures. The TCQ provides a reliable, valid, and convenient measure of subjective cognitive dysfunction in patients with MDD.

摘要

认知功能障碍与重度抑郁症(MDD)患者的功能损害有关。本研究旨在探讨MDD患者认知障碍的相关因素,并开发和验证一份简短且与文化相关的问卷——台湾认知问卷(TCQ)。这是一项针对台湾MDD患者的横断面、多中心观察性研究。来自10个中心的第1组参与者通过其回答和社会人口统计学数据对TCQ进行了验证。来自一个中心的第2组参与者接受了客观认知评估,以明确TCQ得分与其相关因素之间的关系。在第1组中,招募了493名参与者。在第2组中,又额外招募了100名参与者。TCQ的总体Cronbach's alpha系数为0.908。根据ROC曲线的坐标,9/10是理想的截断点。按照该标准,TCQ的敏感性/特异性为0.610/0.689。TCQ得分与急性精神科住院史及抑郁严重程度呈正相关,与客观认知指标呈负相关。TCQ为MDD患者主观认知功能障碍提供了一种可靠、有效且便捷的测量方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b71/8949511/2b094ae6532d/jpm-12-00359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b71/8949511/2b094ae6532d/jpm-12-00359-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b71/8949511/2b094ae6532d/jpm-12-00359-g001.jpg

相似文献

1
A Multi-Center Study for the Development of the Taiwan Cognition Questionnaire (TCQ) in Major Depressive Disorder.一项关于开发用于重度抑郁症的台湾认知问卷(TCQ)的多中心研究。
J Pers Med. 2022 Feb 26;12(3):359. doi: 10.3390/jpm12030359.
2
Taiwanese Depression Questionnaire and AD8 Questionnaire for Screening Late-Life Depression in Communities.用于社区老年人抑郁症筛查的台湾抑郁问卷和AD8问卷。
Neuropsychiatr Dis Treat. 2021 Mar 9;17:747-755. doi: 10.2147/NDT.S298233. eCollection 2021.
3
Relationship between cognition and the severity of chronic tinnitus: Validation of the Japanese version of the Tinnitus Cognitions Questionnaire.认知与慢性耳鸣严重程度的关系:耳鸣认知问卷日语版的验证。
Int Tinnitus J. 2021 Mar 1;25(1):112-117. doi: 10.5935/0946-5448.20210020.
4
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.针对美国和英国重度抑郁症患者的感知缺陷问卷-抑郁版(PDQ-D)工具的心理测量学验证。
Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877. doi: 10.2147/NDT.S175188. eCollection 2018.
5
A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA).亚洲重度抑郁症患者使用文拉法辛的真实世界证据的台湾研究(TREVIDA)。
Curr Med Res Opin. 2021 Dec;37(12):2163-2173. doi: 10.1080/03007995.2021.1980869. Epub 2021 Oct 1.
6
Reliability and validity of a Short Form of the Tobacco Craving Questionnaire.《烟草渴望问卷简表》的信度和效度
Nicotine Tob Res. 2008 Apr;10(4):643-51. doi: 10.1080/14622200801908174.
7
Development of the Taiwanese Depression Questionnaire.台湾抑郁问卷的编制
Chang Gung Med J. 2000 Nov;23(11):688-94.
8
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.认知障碍的评估采用 THINC 综合工具(THINC-it):与重度抑郁症的心理社会功能的相关性。
J Affect Disord. 2017 Nov;222:14-20. doi: 10.1016/j.jad.2017.06.036. Epub 2017 Jun 23.
9
What is normal cognition in depression? Prevalence and functional correlates of normative versus idiographic cognitive impairment.在抑郁症中,正常认知是什么?正常与特质认知损伤的患病率和功能相关性。
Neuropsychology. 2021 Jan;35(1):33-41. doi: 10.1037/neu0000717.
10
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).疼痛与重度抑郁症:与通过THINC综合工具(THINC-it)测量的认知障碍的关联。
Scand J Pain. 2017 Apr;15:62-67. doi: 10.1016/j.sjpain.2016.12.004. Epub 2017 Jan 10.

引用本文的文献

1
Does Baseline Cognitive Function Predict the Reduction Rate in HDRS-17 Total Scores in First-Episode, Drug-Naïve Patients with Major Depressive Disorder?基线认知功能能否预测首发、未用过药物的重度抑郁症患者汉密尔顿抑郁量表-17项总分的降低率?
Neuropsychiatr Dis Treat. 2024 Feb 23;20:353-361. doi: 10.2147/NDT.S453447. eCollection 2024.

本文引用的文献

1
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.2020 年 COVID-19 大流行期间 204 个国家和地区的抑郁和焦虑障碍的全球患病率和负担。
Lancet. 2021 Nov 6;398(10312):1700-1712. doi: 10.1016/S0140-6736(21)02143-7. Epub 2021 Oct 8.
2
Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder.发病年龄和体力活动与目前诊断为重度抑郁症患者的认知障碍有关。
J Affect Disord. 2021 Jan 15;279:343-352. doi: 10.1016/j.jad.2020.10.032. Epub 2020 Oct 15.
3
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
4
Duration of untreated illness and depression severity are associated with cognitive impairment in mood disorders.未治疗疾病的持续时间和抑郁严重程度与心境障碍的认知障碍有关。
Int J Psychiatry Clin Pract. 2020 Sep;24(3):227-235. doi: 10.1080/13651501.2020.1757116. Epub 2020 Apr 27.
5
A systematic review of the clinical use of Withania somnifera (Ashwagandha) to ameliorate cognitive dysfunction.一项关于使用南非醉茄(冬虫草)改善认知功能障碍的临床应用的系统评价。
Phytother Res. 2020 Mar;34(3):583-590. doi: 10.1002/ptr.6552. Epub 2019 Nov 19.
6
Childhood trauma and diagnosis of major depression: Association with memory and executive function.儿童期创伤与重度抑郁症诊断:与记忆和执行功能的关联。
Psychiatry Res. 2018 Dec;270:880-886. doi: 10.1016/j.psychres.2018.10.071. Epub 2018 Oct 30.
7
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.针对美国和英国重度抑郁症患者的感知缺陷问卷-抑郁版(PDQ-D)工具的心理测量学验证。
Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877. doi: 10.2147/NDT.S175188. eCollection 2018.
8
The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review.重度抑郁症患者认知障碍与社会心理功能的临床关系:系统综述。
Psychiatry Res. 2018 Nov;269:157-171. doi: 10.1016/j.psychres.2018.08.033. Epub 2018 Aug 15.
9
The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression.精神科认知障碍筛查(SCIP)与重度抑郁症的疾病严重程度和认知主诉相关。
Int J Psychiatry Clin Pract. 2019 Mar;23(1):49-56. doi: 10.1080/13651501.2018.1450512. Epub 2018 Mar 19.
10
Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.治疗重度抑郁症认知症状的药理学方法。
CNS Neurol Disord Drug Targets. 2017;16(8):891-899. doi: 10.2174/1871527316666170919115100.